HIV Self-Testing to Empower Prevention Choices in Sex Workers

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 21, 2018

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
HIV/AIDS
Interventions
DEVICE

OraQuick HIV Self-Test

OraQuick® HIV Self-Test is an in-vitro diagnostic medical device that is used for self-testing of antibodies for HIV-1 and HIV-2 in oral fluid. This test is intended as an aid to detect antibodies to HIV-1 and HIV-2 from infected individuals.

Trial Locations (1)

Unknown

Infectious Diseases Institute,Makerere University College of Health Sciences, Kampala

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

lead

Makerere University

OTHER

NCT03426670 - HIV Self-Testing to Empower Prevention Choices in Sex Workers | Biotech Hunter | Biotech Hunter